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Abstract
Unfavorable maternal diet during pregnancy can predispose the offspring to diseases later in life, such as hypertension,
metabolic syndrome, and obesity. However, the molecular basis for this phenomenon of ‘‘developmental programming’’ is
poorly understood. We have recently shown that a diet nutritionally optimized for pregnancy can nevertheless be harmful
in the context of diabetic pregnancy in the mouse, associated with a high incidence of neural tube defects and intrauterine
growth restriction. We hypothesized that placental abnormalities may contribute to impaired fetal growth in these
pregnancies, and therefore investigated the role of maternal diet in the placenta. LabDiet 5015 diet was associated with
reduced placental growth, commencing at midgestation, when compared to pregnancies in which the diabetic dam was
fed LabDiet 5001 maintenance chow. Furthermore, by quantitative RT-PCR we identify 34 genes whose expression in
placenta at midgestation is modulated by diet, diabetes, or both, establishing biomarkers for gene-environment
interactions in the placenta. These results implicate maternal diet as an important factor in pregnancy complications and
suggest that the early phases of placenta development could be a critical time window for developmental origins of adult
disease.
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Introduction
Maternal diet has long been known to be a key determinant for
pregnancy success. Both undernutrition and malnutrition are
harmful to development of the conceptus, increasing risk for
spontaneous abortions, congenital malformations, and intrauterine
growth restriction [1,2]. However, it is now becoming clear that
overnutrition and excess of particular nutrients, such as with
maternal obesity or diabetes, are also detrimental [3,4,5,6].
Unfavorable maternal diet, as reflected in abnormal birth
weight, is believed to predispose the offspring to diseases later in
life, such as hypertension, metabolic syndrome, and obesity [7,8].
However, it is currently unclear which tissue systems are involved
in this phenomenon of ‘‘developmental programming’’. Using
a mouse model of diabetic pregnancy, we have recently shown that
a diet nutritionally optimized for pregnancy can nevertheless be
harmful [9]. In the context of maternal hyperglycemia, this diet
interacts with maternal metabolic conditions, leading to a more
than three-fold increased rate of neural tube defects compared to
occurrence of these defects when the pregnant diabetic dam is fed
a maintenance chow [9]. Under these adverse conditions even
embryos that were not obviously malformed were nonetheless
negatively affected, as demonstrated by reduced fetal growth. In
particular, while the two diets had similar carbohydrate content,
higher fat content at the expense of protein content (while not
protein-deficient) reduced fetal growth by 18%, and reduced size
was already evident as early as gestational day E9.5, whereas
higher protein and lower fat content reduced fetal growth by
9.3%, and only in late gestation [9]. Although the diets also
differed in some other micronutrient components, these results are
consistent with the notion that macronutrient composition of the
maternal diet modulates the extent of intrauterine growth
restriction in diabetic pregnancies. The impaired fetal growth
clearly suggested that nutrient supply to the fetus was impaired,
and that the placenta, the major conduit of nutrients to the fetus,
might also be compromised.
Indeed, as we reported previously, placental growth was also
reduced in pregnancies affected by maternal hyperglycemia [10].
In addition, we found abnormal cell differentiation and altered
gene expression in the diabetic placenta as early as midgestation
stages in the mouse. This suggested that, similar to adverse effects
on the embryo (malformation) and fetal growth, the unfavorable
maternal diet might also have detrimental effects on placental
development. The present study tested this hypothesis using two
diets, Purina 5001 (LabDiet 5001), a commercial rodent mainte-
nance chow, and Purina 5015 (LabDiet 5015), a commercial diet
specifically recommended for pregnancy and lactation; for ease of
reading, we will refer to 5001 as ‘‘chow’’, and 5015 as ‘‘breeder
diet’’. Our results identified diet-responsive genes in the murine
placenta and their interaction with maternal diabetes. These genes
may play a role not only for diet-induced placental impairment but
also in developmental programming.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38445Results
In order to investigate the effects of maternal diet on the
placenta in diabetic pregnancies, we used the well-established
STZ-induced diabetes FVB mouse model [9,10,11]. Females were
fed either chow or breeder diet for at least 4 weeks before the first
STZ treatment, and were considered diabetic when their blood
glucose levels exceeded 250 mg/dL. They were then mated to
non-diabetic FVB males, and placentas were isolated at various
stages of the pregnancy and wet weight was determined (Figure 1).
Only placentas associated with morphologically normal embryos
were used for this study.
Effect of maternal diet on placenta growth in diabetic
pregnancies
When the dams were fed chow diet, differences between normal
and diabetic placentas were observed at midgestation (E9.5,
E10.5), and at the end of pregnancy (E18.5). Although statistically
significant, the magnitude of weight differences was small: under
10% (recalculated to the normal weight average), and directions of
change -i.e. increase/decrease- were not consistent between time
points (Figure 1, Panel A). In contrast, when dams were fed
breeder diet, the placentas in diabetic dams were consistently
smaller than in normal pregnancies (Figure 1, Panel B). Also, the
differences were generally greater than 10%, with up to 18% at
E18.5. Thus, maternal diabetes during pregnancy is associated
with reduced placenta growth when the breeder diet is consumed.
The breeder diet has little effect on placenta growth in normal
pregnancies, although, compared to chow, significantly higher
placental weights were observed at E9.5 (14.8% increased weight)
and on E12.5 (13% increased weight) (Figure 1, Panel C). Thus,
the breeder diet, which contains more fat, may promote placenta
growth some stages. In contrast, in the context of a diabetic
pregnancy (Figure 1, Panel D), the breeder diet is consistently
associated with significantly lower placenta weight from E10.5 on,
through late stages of pregnancy. In these diabetic pregancies,
placenta weight was reduced by ,8% at E10.5 and E12.5, and up
to ,15% at E15.5 and E18.5 (calculated relative to the chow diet).
Thus, reduced placenta growth with breeder diet is due to a diet x
diabetes interaction.
This conclusion is further supported when we consider placenta
weights relative to maternal weight during pregnancy (Figure 2).
Diabetic dams had reduced weight gain compared to controls on
both diets (Panels A and B). However, there was no significant
influence of diet on weight gain when either control (C) or diabetic
dams (D) on the different diets were compared. Thus, the
Figure 1: Interaction of maternal diet and maternal diabetes in placenta growth. Placentas were isolated at various time points; the
dissected material consisted of both embryo-derived and maternal portions. Only placentas were used that were associated with morphologically
normal embryos. Wet weight was determined immediately after dissection. n=number of placenta samples. Error bars show standard deviations
from the means. A: Comparison of placenta weights between control and diabetic pregnancies where all dams were fed chow diet. B: Comparison of
placenta weights between control and diabetic pregnancies where all dams were fed breeder diet. C, D: Replotted data from A and B to facilitate
comparison by diet. *: p,0.05; **: p,0.005; ***: p,0.0005. In diabetic dams fed chow diet, placenta weights were indistinguishable from controls by
the end of pregnancy, while in diabetic dams fed breeder diet, placentas were consistently smaller than controls after midgestation.
doi:10.1371/journal.pone.0038445.g001
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maternal diabetes, diet had no significant effect. Therefore,
maternal weight alone cannot explain the reduced placenta
growth in diabetic dams that are fed breeder diet.
The relationship of placenta size to maternal weight is depicted
in Figure 3: maternal weight at time of sacrifice is plotted along the
x-axis, with all placenta weights for that individual’s pregnancy
plotted vertically along the y-axis. The distributions for normal
pregnancies are very similar between chow-fed and breeder-diet-
fed dams in both dimensions; accordingly, the shapes of the
polynomial curves that describe the data are very similar as well.
In contrast, peak maternal weights in diabetic pregnancies remain
lower (compare the extension of data points along the x-axis
between panels A-C and B-D, respectively). While the shape of the
polynomial curve for placentas from diabetic chow-fed dams
resembles that of normal pregnancies, the curve for diabetic
pregnancies under conditions of breeder diet is clearly distinct
(Figure 3E); with a reduction in height relative to the y-axis. This is
also the case when placenta weights are plotted relative to day of
dissection (Figure 3F). The placentas from diabetic dams fed the
breeder diet substantially fail to expand during the second half of
the pregnancy. This indicates that, although the effects of the diet
x diabetes interaction on placenta growth are most pronounced in
late pregnancy, underlying mechanisms controlling growth must
already have been affected at midgestation. This proposition
provided the rationale to investigate the effects of maternal diet on
gene expression in the diabetic placenta at the midgestational
E10.5 time point.
Effect of maternal diet on placental gene expression in
diabetic pregnancies
We previously published that, under conditions of maternal
diabetes, placental gene expression is dysregulated by E10.5,
labyrinth and junctional layer are reduced, and spongiotropho-
blast migration is aberrant [10]. From this evidence and the
literature, we selected 34 genes according to the following criteria:
detectable expression in both control and diabetic samples,
significant fold-change between these conditions, novelty of
detection of a given gene in placenta, annotation for roles in
metabolism, cell migration and proliferation, or on the basis of
known cell specificity. For some of these genes, in fact, our results
are the first to demonstrate expression in the placenta. Figure 4
displays the expression levels of each gene in control (normal
pregnancies) and diabetic placentas for pregnancies where the
dams were fed either chow or breeder diet, respectively (each
group consisted of 6 samples from independent pregnancies;
n=6). For ease of visualization, ‘‘fold-change’’ of expression
differences from the level in the normal/chow condition (set to 1)
was plotted.
Figure 2: Effects of diet and diabetes on maternal weight gain. Pregnant females were weighed on the day the copulation plug was detected
(E0.5), and before sacrifice. Weight gain was calculated as the difference between weight on E18.5 and E0.5. Bar diagrams depict means and standard
deviations. A: On chow diet, diabetic dams gain less weight (p=5.69x10
26 versus non-diabetic dams). B: On breeder diet, diabetic dams also gain less
weight (p=1.5x10
24 versus non-diabetic dams on breeder diet). C, D: Replotted data from A and B to facilitate comparison by diet. Differences
between group means in C and D, respectively, are not statistically significant.
doi:10.1371/journal.pone.0038445.g002
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38445Figure 3: Relationship of placenta size to maternal weight – interaction of diet and diabetes. For each pregnant dam, her weight at
sacrifice (timepoints from E9.5 to E18.5) was plotted along the X-axis, and the weights of placentas associated with morphologically normal embryos
from her pregnancy were plotted along the Y-axis. Polynomial distributions were fitted to the data for A: Control dams fed chow diet; B: Control dams
fed breeder diet; C: Diabetic dams fed chow diet: and D: Diabetic dams fed breeder diet. E: Comparison of the polynomial curves shows that the
distribution of placenta weights during the pregnancy is very similar for all groups, except for the group of diabetic dams that were fed breeder diet.
F: Comparison of polynomial distributions when the data are plotted by day of placenta isolation. Again, the results for diabetic dams on breeder diet
reveal a specific interaction between diet and diabetes on placenta growth.
doi:10.1371/journal.pone.0038445.g003
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affected gene expression in the placenta at E10.5: Ptges2 (encoding
prostaglandin E synthase 2) was responsive to diet only in normal
dams, such that breeder diet was associated with lower expression.
When chow diet was consumed, expression of this gene was
responsive to diabetes, resulting in lower expression; breeder diet
did not further reduce its level in diabetic dams. While significant
in two comparisons, the magnitude of changes for this gene was
rather moderate. Crct1 (cysteine-rich C-terminal protein 1) and
Mmp1a (matrix metallopeptidase 1a, interstitial collagenase)
expression levels were also modulated by diet only in normal
pregnancies, but diabetes had an effect in dams fed the breeder
diet. Atoh8 (atonal homolog 8), Pcsk5 (proprotein convertase
subtilisin/kexin type 5), Mpzl2 (myelin protein zero-like 2), TpbpB
(trophoblast specific protein beta), and Spink8 (serine peptidsase
inhibitor, Kazal type 8) were responsive to diet only under
conditions of maternal hyperglycemia, and responsive to diabetes
only under chow feeding conditions. Conversely, 9130005N14R,
Thsd4 (thrombospondin type 1 domain containing 4), and Il17b
(interleukin 17B) were also responsive to diet only under conditions
of hyperglycemia, but then responded to diabetes when breeder
diet was consumed. In each of these subsets, response to diet or
diabetes was restricted to one modality only. This was also found
for one group of genes that were not responsive to diabetes at all
but solely to diet. Usp24 (ubiquitin specific peptidase 24), Adamts6
(ADAM metallopeptidase with thrombospondin type 1 motif 6),
Thbs2 (thrombospondin 2), and Frem1 (Fras1 related extracellular
matrix protein 1) exhibited diet response only in normal dams, and
Csf2rb (colony stimulating factor 2 receptor beta) only in diabetic
dams. It is interesting to note that the directions of changes in
expression levels were diverse for different genes within each
subset. However, for the three genes that respond only to diet
regardless of metabolic condition, i.e. Tm9sf1 (transmembrane 9
superfamily member 1), Ermp1 (endoplasmic reticulum metallo-
peptidase 1), and Ptgs2 (prostaglandin-endoperoxide synthase 2),
breeder diet was always associated with increased expression
levels. Elevated and reduced expression levels were found for the
group of genes that respond to diet under any condition but to
diabetes only with breeder diet, constituted by the Kcnk2
(potassium channel subfamily K member 2), Mmp13 (matrix
metallopeptidase 13), Hpgd (hydroxyprostaglandin dehydrogenase
15), and Cyp1a1 (cytochromome P450 family 1 subfamily a poly-
peptide 1) genes. Lpl (lipoprotein lipase) was not the only gene that
responded to diabetes only regardless of diet; a larger study of
diabetes-regulated genes will be published elsewhere [Kruger et
al., unpublished results]. Pappa2 (pappalysin 2), Ankrd2 (ankyrin
repeat domain 2), Pla2g5 (phospholipase A2 group V), Slc6a4
(solute carrier family 6 member 4, serotonin transporter), and
Prl5a1 (prolactin family 5 submaily a member 1) levels were also
altered by maternal hyperglycemia, but diet had an effect only in
normal pregnancies. In contrast, Tgfßi (transforming growth factor
beta induced), while responsive to hyperglycemia, responded to
diet only in the diabetic condition.
Finally, the group comprised of Mmp15 (matrix metallopepti-
dase 15), Rassf4 (ras association domain family member 4), Pfpl
(pore forming protein-like), and Spi16 (serine protease inhibitor 16)
responded to both diabetes and diet, in all combinations. Notably,
while the pattern of response may be similar for genes within one
subset, the direction of change by diet, or by diabetes, can be
different: for example, among the genes responsive to diet in both
metabolic states but to diabetes only with breeder diet, Kcnk2 and
Mmp13 expression levels are reduced by breeder diet, and
increased by diabetes with the breeder diet. In contrast, Hpgd
expression is increased by breeder diet, and also increased by
diabetes. An even more complex response is exhibited by Cyp1a1,
which displays antipodal responses in normal compared to
diabetic conditions: the breeder diet reduces expression in
placentas from normal dams, but increases expression in placentas
from diabetic dams. These complex patterns of changes in gene
expression levels suggest that within a given subset of genes that
Figure 4: Interaction of maternal diet and diabetes on gene expression in the placenta. For each experimental group, gene expression
levels were determined by quantitative real-time PCR (see Table 3). From the DCt-values, ‘‘fold-change‘‘ of expression levels was determined relative
to the expression level in placentas from normal dams on chow diet. * indicates that the difference between groups is statistically significant. Note
that the Y-axis dimensions are different for some panels.
doi:10.1371/journal.pone.0038445.g004
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different mechanisms exist for their regulation by the metabolic
and diet conditions.
It is noteworthy that, even though the selection of genes
investigated here was not random, almost all possible responses,
based upon statistical significance of changes, were reflected in our
data: with comparisons between 4 conditions, 16 response patterns
are theoretically possible (see Table 1). We are not considering
patterns 1 (no response at all), 4 and 5 (response to diabetes in only
one or the other diet condition) here, since data for these have
been published previously [10]. Intriguingly, of the remaining 13
possibilities, 12 patterns were represented in our results, 8 by more
than one gene. We currently do not know whether the one
undetected possibility (pattern 12) could be represented in a larger
gene set, or whether there are biological reasons for the absence.
Nonetheless, these data show that our results cover the majority of
the possible spectrum for responsiveness. It is obvious that the
matrix derived from these data allows classification of genes by
virtue of response patterns. Furthermore, the results demonstrate
that patterns of response are diverse and that condition-specific
response patterns exist; therefore, our findings implicate multiple
mechanisms in diet- and diabetes-responsive gene regulation in the
placenta.
This is also evident when the magnitude of changes is
considered. Figure 5 displays a hierarchical cluster analysis, where
the intensity of color indicates the magnitude of change (blue for
increased, yellow for decreased expression relative to the chow diet
condition). Genes where diabetes explains more than 50% of the
experimental variation -as per Table 1- cluster together as
increased (blue) or decreased (yellow) respectively, as indicated
by the red brackets. Two of 4 genes where diet explains more than
50% of the variation also cluster together (black bracket).
Additional clusters with smaller magnitude of differences in gene
expression levels by metabolic and diet condition also appear in
this analysis. This provides further evidence in support of the
argument for multiple mechanisms. The distinct clustering of
genes that respond to either diet or diabetes implies that these
genes by themselves can indicate exposure, based upon their
expression levels and change from the control.
Interactions of diet and diabetes on gene expression in
the placenta
We then attempted to determine the ‘‘strength’’ of effects of diet
and diabetes on gene expression, and potential interactions of both
conditions, by performing 2-factor ANOVA statistical tests. These
revealed statistically significant interactions between both modal-
ities for only a fraction (11 of 34=32.3%) of the genes (Table 2).
The extent of variation in placental gene expression explained by
the interaction of both factors, metabolic status x diet, varies, with
decreasing importance for expression of Rassf4, Cyp1a1, Mpzl2,
Thsd4, 9130005N14R, TpbpB, IL17b, Ankrd2, Pfpl, Prl5a1, and
Mmp13. Of these, Cyp1a1, TpbpB, IL17b, Ankrd2, Pfpl, and Prl5a1
are more responsive to diabetes (with increasing importance of the
diabetes factor), and Mmp13 is more responsive to diet. The
greater number of diabetes-responsive genes in this group is likely
a reflection of our strategy to select genes from a microarray
comparison between diabetic and control placentas [10]. It is
noteworthy that the direction of interactions is diverse within this
group, as is the relative contribution of metabolic status or diet,
providing further support for the proposition that multiple
mechanisms of regulation could be involved.
Table 1: Patterns of statistical significance of placental gene responses in comparisons between conditions.
Comparison
Chow vs.
Breeder
Chow vs.
Breeder
Normal vs.
Diabetic
Normal vs.
Diabetic
Condition Normal Diabetic Chow Breeder diet
Pattern # Gene Names
1 22 2 2
2 + 222 Usp24, Adamts6, Thbs2, Frem1
3 2 + 22 Csf2rb
4 22 + 2
5 22 2 +
6 + + 22 Tm9sf1, Ermp1, Ptgs2
7 2 + + 2 Atoh8, Mpzl2, Pcsk5, Spink8, Tpbpb
8 22 + + Lpl
9 + 22+ Crct1, Mmp1a
10 + 2 + 2 Ptges2
11 2 + 2 + 9130005N14R, Il17b, Thsd4
12 + + + 2
13 2 + + + Tgfßi
14 + 2 + + Ankrd2, Pappa2, Pla2g5, Prl5a1, Slc6a4
15 + + 2 + Kcnk2, Mmp13, Hpgd, Cyp1a1,
16 + + + + Mmp15, Rassf4, Pfpl, Spi16
Comparisons were made for each gene between placentas from chow- and breeder diet-fed normal dams, between placentas from chow and breeder diet-fed diabetic
dams, between placentas from normal and diabetic dams fed chow, and between placentas from normal and diabetic dams on breeder diet. Statistical significance by
two-tailed t-test for any one comparison is indicated as "+" for comparisons where P is ,0.05 (significant), and "2" for P.0.05 (not significant). The response pattern for
each gene was determined by virtue of the distribution of significances in these 4 comparisons. vs. = versus.
doi:10.1371/journal.pone.0038445.t001
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detected for 23 genes, 12 of these genes were nonetheless regulated
by both diabetes and diet; given the lack of statistically detectable
interactions, we presume that the effects of both factors are
independent of each other. We can further classify the response
patterns of these genes, as predominantly regulated by diet (in
descending order of explanatory value of the diet factor): Spi16,
Kcnk2, Hpgd, Ptgs2, Mmp15,o ra spredominantly regulated by
diabetes: Pappa2, Tgfßi, Slc6a4, Crct1, Spink8, Pcsk5, and Ptges2 (again
in descending order). Finally, genes for which only one factor is
explanatory are either responsive to diabetes only: Pla2g5, Lpl,
Mmp1a, and Atoh8 fall into this group, or responsive to diet only: this
subset is constituted by Ermp1, Tm9sf1, Frem1, Usp24, Adamts6, and
Thbs2. Neither an interaction nor any of the single factors had
significant explanatory value for expression levels of Csf2rb.
The patterns of interactions in response to the environmental
factors diet and diabetes are schematically depicted in Figure 6.
Our finding that diabetes and diet act independently on expression
of the majority (67.6%) of these genes indicates that they would be
excellent biomarkers to detect exposure to different diets, with or
without hyperglycemia. For example, high expression of Pla2g5
and/or Prl5a1, as well as low expression of Ankrd2 and/or
Pappa2, indicates exposure to diabetes, while low expression of
Kcnk2 and/or Mmp13 indicates exposure to breeder diet.
Together with other genes that respond more strongly to diet
than diabetes, our results therefore identify biomarkers for adverse
diet exposure in early stages of placenta formation. These
molecular markers will therefore be most useful in helping to
define the potentially detrimental components in the breeder diet,
or any other diet.
Discussion
We here report that maternal diet affects placental growth and
gene expression in diabetic pregnancies. In the context of maternal
diabetes, the diet recommended specifically for breeding and
lactating mice was associated with reduced fetal size [9] and
decreased placental size (as measured by weight), indicating that
there is a specific interaction of diet with the diabetic condition on
placenta growth. Conceivably, this could potentially be linked to
reduced consumption of the diet. When fed breeder diet, diabetic
dams had reduced weight gain compared to normal dams on this
diet, but diabetic chow-fed dams also had reduced weight gain.
Thus, reduced weight gain is attributable to the metabolic
condition, independent of diet. Interestingly, normal dams gained
similar amounts of weight with either diet, indicating that
differences in caloric content of the diets had no noticeable
influence on maternal weight under normal conditions. With the
metabolic derangements of maternal diabetes, however, the
difference between the two diets had a strong influence on the
differential decrease in placental weight: in comparison to chow-
fed diabetic dams, the breeder diet-fed diabetic dams had
significantly reduced placenta growth.
Litter size is known to be inversely correlated to placenta size
[12,13].However,inourexperiments,littersizedidnotsignificantly
differ between diabetic pregnancies when the dam was fed breeder
dietcomparedtotheotherconditions[9].Thus,littersizeisunlikely
to serve as an explanation for reduced placenta growth. It should be
kept in mind, that the present study included only placentas that
were associated with morphologically normal embryos; analyses on
placentas associated with abnormal embryonic development in
diabetic pregnancies have yet to conducted.
Interestingly, maternal glucose levels were higher at the start of
pregnancy when diabetic dams consumed breeder diet, averaging
349.65697.79 mg/dL compared to 306.23681.81 mg/dL in
diabetic dams consuming the chow diet. By the time of sacrifice,
maternal glucose levels exceeded the upper limit of the meter
(600 mg/dL) in 9 out of 53 dams on chow diet, and in 29 out of 45
dams on breeder diet (we therefore cannot estimate average levels
for the whole group); measurable blood glucose levels in the
remaining dams were 457.50690.61 mg/dL in chow-fed (n=26),
and 506682.13 mg/dL in breeder diet-fed diabetic dams (n=16),
respectively (difference is not statistically significant). Also, if we
consider the difference between pre-pregnancy glucose levels and
those at sacrifice [9] as an indicator of diabetes severity, there was
only a weak relationship to placenta growth in diabetic pregnan-
cies, regardless of diet. Dam weight at copulation was 22.4661.8 g
(n=27) for breeder diet-fed diabetic dams, which was approxi-
mately 1g less than normal dams (23.562.1 g; n=48) on breeder
diet. However, compared to diabetic dams on chow diet, the
weights, and the weight gains, of breeder diet-fed diabetic dams
were indistinguishable throughout pregnancy. Thus, we consider it
unlikely that solely the degree of maternal hyperglycemia, or
maternal size or weight gain, could have been responsible for the
reduced placenta size in breeder diet-fed diabetic pregnancies.
Because our data do not implicate maternal factors other than diet
in the reduced growth of placentas in diabetic pregnancies, we
therefore conclude that diet is the major factor influencing
placenta growth in this model.
The gene expression profiles indicate that breeder diet does not
simply exacerbate the detrimental effects of maternal diabetes, but
that it has distinct effects. While gene expression is clearly
Figure 5: Cluster analysis of diet- and diabetes-responsive
gene expression in the placenta. The ‘‘fold-change’’ results for each
group and gene were clustered in Cluster 3 and plotted in TreeView as
a heat map, with blue representing increased and yellow decreased
expression, with black representing no change. The genes most
indicative of exposure to diet or diabetes are highlighted by brackets
(red for diabetes, black for diet). C: chow diet; B: breeder diet; CD: chow
diet, diabetic; BD: breeder diet, diabetic.
doi:10.1371/journal.pone.0038445.g005
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magnitude and direction of changes, and exert their effects on
specific sub-sets of genes. Except for Tgfßi and Il17ß, where gene
expression levels in diabetic placentas could be interpreted to
correlate with blood glucose levels (magnitude of change is greater
in the breeder diet-fed group than in the chow-fed), all other
patterns are indicative of interaction of diet and diabetic state, in
additive manner, and often also in opposite directions (see
Figure 4). Examples to illustrate additive effects are Thbs2, Ptgs2,
Hpgd, Slc6a4, Mmp15, Pfpl, and Spi 16; examples for opposite
direction of the diet effect in normal compared to diabetic dams
are Crct1, Mmp1a, Atoh8, Cyp1a1, Pappa2, Ankrd2, Prl5a1, and
Rassf4. In addition, our results reveal several genes that can serve
as indicators of diet exposure in the absence of and regardless of
maternal diabetes, such as Usp24, Adamts6, Frem1, Tm9sf1,
Emp1, Ptgs2, Kcnk2, Mmp13 and Mmp15. These patterns, and
particularly those of opposite interactions, imply that the adverse
effect of breeder diet on placenta growth acts through mechanisms
other than hyperglycemia alone. Thus, we have identified diet-
dependent targets, of which some interact with maternal diabetes
in regulating gene expression in the placenta at midgestation.
Less clear at the moment is how these molecular alterations
translate into reduced placental growth. We have previously
shown that spongiotrophoblast growth is reduced under conditions
of diabetic pregnancy, and the labyrinth also remains smaller [10].
We also reported reduced levels of Ascl2 (achaete-scute complex
Table 2: Fraction (n %) of variation in gene expression between modalities explained by each factor, and their interaction.
Interaction p-value Diet p-value Diabetes p-value
Gene name
9130005N14R 24.77 0.0117 0.54 0.6800 10.24 0.0800
Adamts6 4.41 0.2591 29.66 0.0069 0.59 0.6751
Ankrd2 9.73 0.0196 0.22 0.7049 59.81 ,0.0001
Atoh8 2.17 0.4048 12.28 0.0563 25.70 0.0083
Crct1 8.99 0.0730 11.99 0.0409 28.83 0.0029
Csf2rb 13.59 0.0790 6.50 0.2160 0.32 0.7790
Cyp1a1 37.34 0.0001 0.26 0.6977 28.76 0.0005
Ermp1 0.45 0.5561 71.20 ,0.0001 1.88 0.2470
Frem1 0.36 0.7392 36.42 0.0027 0.79 0.6203
Hpgd 2.77 0.2400 42.65 0.0001 16.37 0.0083
Il17b 13.82 0.0226 5.00 0.1527 35.90 0.0007
Kcnk2 5.77 0.0618 57.99 ,0.0001 6.74 0.0451
Lpl 3.98 0.1660 0.04 0.8904 57.49 ,0.0001
Mmp13 4.35 0.0250 79.55 ,0.0001 1.27 0.2054
Mmp1a 4.65 0.1549 0.82 0.5420 51.99 ,0.0001
Mpzl2 27.70 0.0104 2.06 0.4491 1.06 0.5866
MT2-Mmp 0.21 0.7556 31.56 0.0009 26.25 0.0021
Pappa2 1.30 0.1800 5.17 0.0120 83.52 ,0.0001
Pcsk5 1.07 0.5650 14.36 0.0445 22.10 0.0150
Pfpl 6.36 0.0221 20.21 0.0003 52.76 ,0.0001
Pla2g5 0.92 0.4501 1.49 0.3380 66.72 ,0.0001
Prl5a1 5.73 0.0441 4.20 0.0805 65.26 ,0.0001
Ptges2 7.57 0.1308 13.82 0.0459 17.61 0.0261
Ptgs2 0.10 0.8405 34.99 0.0011 17.11 0.0145
Rassf4 49.37 0.0002 2.37 0.3243 1.75 0.3958
Slc6a4 1.39 0.3485 22.50 0.0010 46.04 ,0.0001
Spi16 0.75 0.4013 67.44 ,0.0001 11.55 0.0030
Spink8 0.15 0.8126 18.92 0.0151 27.31 0.0046
Tgfbi 2.92 0.2169 9.28 0.0341 51.90 ,0.0001
Thbs2 0.51 0.6974 22.47 0.0168 10.93 0.0840
Thsd4 26.94 0.0070 3.48 0.2932 9.89 0.0838
Tm9sf1 0.07 0.8660 49.76 0.0002 0.00 0.9949
Tpbpb 15.60 0.0428 1.89 0.4606 15.89 0.0411
Usp24 0.64 0.6553 33.89 0.0035 3.36 0.3109
Statistical significance was evaluated by two-way repeated measures ANOVA, followed by post-hoc Bonferroni correction for multiple testing. Significance where
P,0.05 is indicated by bold font.
doi:10.1371/journal.pone.0038445.t002
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growth of spongiotrophoblasts and the labyrinth [14]. However,
Ascl2 is only regulated by diabetes, not by diet (unpublished
observations), and thus cannot account for the greater extent of
growth reduction of diabetic placentas in breeder diet-fed dams.
More plausible candidates are therefore those genes that exhibit
a response to both diabetes and diet. Among those diet-dependent
genes that could contribute to altered placental growth are genes
known to play a role in inflammation. In this context, the
upregulation by diet of genes encoding thrombospondin-domain
containing proteins (Adamts6, Thbs2, Thsd4) and the downregula-
tion by diet of proteinase inhibitors Spink8 and Spi16 are
noteworthy. Similarly, diet modulates the expression of genes
encoding enzymes that are involved in eicosanoid metabolism,
such as Prostaglandin endoperoxide synthase 2 (Ptgs2/Cox-2), Hydro-
xyprostaglandin dehydrogenase (Hpgd) and Cyp1a1. The enzymes
encoded by these genes are involved in production and
metabolism of prostaglandin E2, and our working model is that
under conditions hyperglycemia and adverse diet, enzymes
catalyzing PGE2 degradation are elevated to levels where they
create a functional PGE2 deficiency, through increased catabolism
of PGE2. Prostaglandin E2 has been shown to stimulate
trophoblast migration [15,16,17] and cellular invasive behavior
[18,19]. Conversely, in experimental animals with reduced PGE2
levels, cell migration is reduced [20,21,22]. Our previous
histological analysis of diabetic placenta revealed aberrant
trophoblast migration and reduced growth of the spongiotropho-
blast layer [10], which is consistent with impaired PGE2 signaling.
Another role of PGE2 is inactivation of Natural Killer Cell activity
in the decidua [23]. Intriguingly, we observe high NK cell
accumulation in the diabetic placenta [10], again consistent with
PGE2 deficiency. A second indication for the involvement of
inflammatory pathways in reduced placental growth is the
upregulation by breeder diet, at least in the diabetic state, of
IL17b, a member of the pro-inflammatory IL17 cytokine family.
The role of inflammatory pathways in aberrant placenta de-
velopment as a consequence of diabetes or diet warrants further
investigation. Also intriguing is the upregulation by breeder diet of
Ubiquitin-specific gene 24 (Usp24) and of Endoplasmic reticulum
metallopeptidase 1 (Ermp1), which could be reflective of altered
protein processing. Taken together, we detect diet influences on
genes with plausible roles in stress responses and inflammation;
further studies will be required to demonstrate a functional
relation to placental development and growth.
It is noteworthy that our -admittedly short- list of 33 diet-
responsive genes does not overlap with the gene repertoire changes
reported for placentas from protein restricted FVB dams at E17.5
[24], or for a comparison of low fat and high fat content diets in
NIH Swiss dams at E12.5 [25]. Non-congruency could be
explained by the different times of sampling, use of different diets,
and the fact that our breeder diet (Purina 5015) was used as the
control diet in the second paradigm, which also encompasses
a strain difference. Yet, the most important feature in our study is
the presence of maternal diabetes as a second environmental
factor that produces the sensitizing condition under which the
adverse effects of breeder diet on placental growth, and the novel
interactions of diet and diabetes on gene expression that we have
identified here, are revealed.
The molecular mechanisms through which diet affects the
regulation of genes with altered expression levels are unknown. To
date, regulatory elements that confer placenta-specific expression
have not been identified for any of the diet targets our work
uncovered. Similarly, it is unknown whether microRNAs or other
epigenetic mechanisms may be involved. Changes in cellular
composition, namely increased frequency of cells expressing the
respective gene, appear to be responsible for the increased
expression of the Serotonin transporter (Slc6a4) and Cyp1a1 genes in
diabetic placenta [10]. Yet, we do not currently know to what
extent, and if so, how any particular diet affects the cellular make-
up of the placenta.
Both the chow, as well as the breeder diet, are formulated to be
replete for minerals and micronutrients, but they differ in
macronutrient composition. In particular, protein content is
higher in the chow diet, while fat is enriched in the breeder diet.
From our results, it appears that placental cells can detect this
difference, likely through nutrient sensing mechanisms [26,27].
The mTOR system plays a prominent role in nutrient sensing, and
it has recently been shown to be present in placenta [28,29].
Although we did not obtain evidence from our microarrays for
altered expression of genes in the mTOR pathway in diabetic
placenta [10], it would be expected to play a role in response to
different diets. It should also be kept in mind that, although
‘‘defined’’ in their composition, both diets are manufactured from
natural ingredients, such as soybean-derived products and fish
meal, the quality and molecular composition of which can be
variable. In this regard, it is important to note that in normal
pregnancies, Cyp1a1 expression is decreased by breeder diet,
providing evidence that this diet is not simply contaminated with
unidentified toxins. Nonetheless, assays with purified ingredient
diets are necessary to determine which of the components in the
breeder diet is/are responsible for deficient placental development.
The 33 diet-responsive genes we have identified in the present
study will be most valuable in monitoring exposure to different
nutritional conditions and perturbations.
Taken together, our results demonstrate that maternal diet
modulates placental gene expression and growth, with a concom-
itant effect on fetal growth [9]. Because deviations from normal
birth weight are linked to adult disease risk, the placental
alterations we find in response to diet and diabetes may have
important implications for developmental programming of
susceptibility to disease later in life [30,31].
Methods
Animals, induction of diabetes, and diets
Mice of the FVB inbred strain were obtained from The Jackson
Laboratories (Bar Harbor, ME) at the age of 5–6 weeks old and
were accomodated to the animal facility for one week before any
Figure 6: Interactive and independent action of maternal diet
and diabetes on gene expression in the placenta. The influence
(color) or lack thereof (empty field) of each factor, and their interaction
was taken from Table 2, with highlighting for interactions in green, for
diet in orange, and for diabetes in red. The number of genes in each
category is given on the left.
doi:10.1371/journal.pone.0038445.g006
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injections of Streptozotocin within a week as previously described
[9,10,11]; when their glucose levels exceeded 250 mg/dL, mice
were set up for breeding, but no earlier than at least 7 days after
the last STZ injection. The day of detection of a vaginal plug in
the morning was termed gestational day 0.5 (E0.5). Details for
glucose and weight measurements of the dams used in this study
have been published [9]. All animal experimentation was done
with approval by the Pennington Biomedical Research Center
Institutional Animal Care and Use Committee, in accordance with
‘Principles of laboratory animal care’ (NIH publication no. 85–23,
revised 1985; http://grants1.nih.gov/grants/olaw/references/
phspol.htm) and applicable federal and state regulations. Diets
were obtained from LabDiet/Purina Mills International (Rich-
mond, IN). The standard diet was Purina 5001 (chow) until the
females were placed into two groups for the experiments at the age
of 8 weeks: one group was fed Purina 5001 (chow) and the other
group received Purina 5015 (breeder diet) from thereon. The
manufacturer states that Purina 5001 has a physiological fuel value
of 3.36 kcal/g, with 28.5% of calories are derived from protein,
13.5% from fat, and 58% from carbohydrates, and Purina 5015
a physiological fuel value of 3.83 kcal/g, 19.8% of calories are
derived from protein, 25.3% from fat, and 54.8% from
carbohydrates (http://www.labdiet.com/rodent_diet.html).
Table 3: Primers for used for quantitative real-time PCR assays.
Gene
symbol
Accession
#
Forward
primer – sequence Position
Reverse
primer – sequnce Position
Exon-exon
boundary AE
9130005
N14Rik
NM_026667 GAAGTCACTGCACGCTGCAT 1438–1457 CTGTGGTTAATTTTATCAGAACTCTTGCT 1555–1527 yes 1.89
Adamts6 NM_001081020 GGTCAGGTGTATGATGCTGATGA 2138–2160 AGCTCTCTACACACTTCCCCATATTT 2226–2201 yes 1.90
Ankrd2 NM_020033 GACACCAACGTGAGAGACAAGCT 644–666 CACAATCTCCACGTGTCCAGTAC 718–696 yes 1.93
Atoh8 NM_153778 GGGCGAGCCAAGAAACG 1356–1372 CTGGTGGTCCCAGCTTTCTC 1459–1440 yes 1.96
Crct1 NM_028798 CTTCTGCCTAGCAGGTGTCAAGT 4–26 CGGCGTTTGTCAAGATGAATTAG 91–69 yes 1.88
Csf2rb NM_007780 CTTCGCTTTGGCTGTGTCTCT 1615–1635 GACCTTTACCTCCATCCTGGAA 1717–1696 yes 1.91
Cyp1a1 NM_009992 AAGAGATACAAGTCTGAATGGCTTCTATATC 1222–1252 AGGCCGGAACTCGTTTGG 1336–1319 yes 1.86
Ermp1 NM_001081213 AGTGCCGTCTGGGTAGTTTTTC 1704–1725 GCCCGTAAAGATATGGGATAAACA 1833–1810 yes 1.95
Frem1 NM_177863 ACAAAAGCGGCGGTGAAA 5834–5851 GAAGTGGTGAGCGAGGATGAG 5973–5953 yes 1.91
Hpgd NM_008278 GACCTATCTTGGTTTGGATTACATGAG 369–395 GAGCCCTGCTAATGAAGACATATTG 453–429 yes 1.90
Il17b NM_019508 GCCAAGAAGAAATGTGAAGTCAATCT 287–312 GGGTCGTGGTTGATGCTGTA 375–356 yes 1.97
Kcnk2 NM_010607 GTGGTTATCACTCTGACGACCATT 778–801 AGGCTTGTAGAAGTCCAGATATTCAAT 861–835 yes 1.89
Lpl NM_008509 TTATCCCAATGGAGGCACTTTC 958–979 CCACGTCTCCGAGTCCTCTCT 1043–1223 yes 1.88
Mmp1a NM_032006 AGGCAGGTTCTACATTCGGGTAA 941–963 TGGCCAGAGAATACCTATTAAATTGA 1013–988 yes 1.95
Mmp13 NM_008607 AATCTATGATGGCACTGCTGACAT 478–501 GTTTGGTCCAGGAGGAAAAGC 595–575 yes 1.84
Mmp15 NM_008609 ATGCAGCCTACACCTACTTCTACAAG 2085–2110 CCATGAAGTCCCGCAGGAT 2192–2174 yes 1.89
Mpzl2 NM_007962 GGGCGGACAGTGCTGATAAA 728–747 TCCACAAAAACAGAGACCTTGTTTC 815–791 yes 1.92
Pappa NM_021362 GAGTGCAAGTTGGGCTTCTTAAA 10045–10067 AGAGACCCAAGAAAGCAACTCAA 10130–10107 no 1.93
Pcsk5 NM_001163144 GCAAGGGCGGGTTAAGTCTT 2303–2322 TGGCAGTCGTGACCATTGA 2384–2366 yes 1.89
Pfpl NM_019540 AACCAGTGTTGTGGAGACTCCAA 2583–2605 AATTCTAACTGTGCAGCAGACAGAAA 2699–2674 no 1.89
Pla2g5 NM_001122954 CCCAAGGATGGCACTGATTG 460–479 TCCGAATGGCACAGTCTTTTT 541–521 yes 1.88
Prl5a1 NM_023746 CAAACAACAAAAGGAAGGCTGAA 346–368 GCAGCCAGCATTCTAATTGTCA 418–397 yes 1.89
Ptges2 NM_133783 TGCCATGTACCTCATCAGCAA 1228–1248 AGAGGTCTACCCGTACATCATCCT 1298–1275 yes 1.90
Ptgs2 NM_011198 CAACAACTCCATCCTCCTGGAA 1285–1306 GAGGCCTTTGCCACTGCTT 1410–1392 yes 1.86
Rassf4 NM_178045 GACCAACGTCCGGGTTAACA 667–686 CCAGACTCATGGACGGTGTAGAG 786–764 yes 1.89
Slc6a4 NM_010484 TGGCCATCAGCCCTCTGT 1813–1830 TGTATTGGAAAAGCCGGAGTTG 1893–1872 yes 1.83
Spi16 U96702 TGACCGCCCATTCCTTTTC 363–381 GAAGAGAACCTGCCACAGAACAA 434–412 no 1.95
Spink8 NM_183136 GGCCAGCTCAGTGTGGACTT 171–190 AAGCTCCCCGGTCATGTG 243–226 yes 1.98
Tgfbi NM_009369 CGGTGTGGTCTATGCCATCA 1930–1949 GCTGACGCCTGTTTGAAGATT 2040–2020 yes 1.69
Thbs2 NM_011581 CAGGTGGCACCTGATTCACA 3693–3712 GCGTAGGTTTGGTCATAAATTGG 3800–3778 yes 1.81
Thsd4 NM_172444 CAGCTTCCTGGCACATTGC 450–468 GAGCCCCTGAATACGTCAAAAG 587–566 no 1.97
Tm9sf1 NM_028780 GAGCCACTTCTACCGGCAAA 1461–1480 AAGTCAGGAAGAAAGGCACAGAGA 1552–1529 yes 1.95
Tpbpb NM_026429 CAGAGAGTGGCGATGGGTTT 406–425 TGTTTCACTCGTTGCCTAACTTCA 487–464 yes 1.88
Usp24 NM_183225 CATCAGTTCAGTCTCCATATAGATCAACA 2972–3000 AATAGTTCGTGGGACAGAGTAGAAGTC 3087–3061 yes 1.80
Primer sequences and positions on the reference sequence are given. Where possible, primers were designed to span an exon-exon junction so as to avoid amplification
from potentially contaminating DNA. Amplification efficiencies were calculated from the actual PCR runs as described before.
doi:10.1371/journal.pone.0038445.t003
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At designated days, uterine horns were dissected out, and pairs
of placentas and embryos were isolated. Placentas included
embryo-derived and maternal tissue, and were dissected in PBS,
briefly blotted on tissue paper to remove excess liquid, and then
they were weighed [10]. Only placentas associated with morpho-
logically normal embryos were used for this study.
Quantitative real-time PCR
Details of the quantitative real-time PCR (Q-RT-PCR) method
have been described elsewhere [10,32]. Primer pairs used in this
study are listed in Table 3. The data analysis for the PCR results
was also previously described [11], including normalization to
Polymerase epsilon 4 (Pole4) expression, and calculation of amplifi-
cation efficiencies and fold changes. Statistical tests were done on
DCt values for a group size of 6 per modality. All assays were
performed on at least 6 placentas, each from an independent
pregnancy, for each metabolic condition and diet modality.
Statistical evaluation
Results were evaluated for statistical significance by using two-
tailed T-tests for pairwise comparisons. P-values smaller than 0.05
were considered statistically significant. For the interaction
analyses, two-factor repeated measures ANOVA was applied,
with Bonferroni post-hoc correction for multiple testing, as
implemented in GraphPad Prism version 4.
Cluster analyses were performed in Cluster 3 (http://rana.lbl.
gov/EisenSoftware.htm) by hierarchical clustering of genes using
the fold-change data depicted in Figure 4, without any data
filtering or adjustments, based on Euclidian distance, with
complete linkage. Visualization was done with Java TreeView
(http://jtreeview.sourceforge.net/).
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